GSK defeats challenge to breakthrough RSV vaccine patent

Intellectual Property 2018-11-26 9:39 pm By Cat Fredenburgh | Melbourne

GlaxoSmithKline has won approval for a patent for a vaccine to prevent a common respiratory virus affecting infants, beating out a challenge from a rival that has developed a competing vaccine.